Infection Expert: Don't Rush to Change MRSA Protocols
What hospitals should do wherever they are is what has long been recommended policy and practice, Wright suggests. And that means they should continue to conduct routine risk assessments to determine how well their infection control strategies are working.
"Ask yourselves how do your rates compare to the rates found in each of the three (research) groups," Wright says. "How do your processes compare, say, if you screen, isolate, and decolonize, or screen and decolonize, or screen and isolate and don't decolonize. How do you fit into the three groups published, and make a decision from there whether to change practice."
"If you're doing better than what was published, or you're doing better than you had been doing and are continuing to go down, or if your rates are lower than anything that's been published in your state or published in some of the national benchmarks," perhaps no change is necessary, he says.
The Centers for Disease Control and Prevention intends to have its Healthcare Infection Control Practices Advisory Committee review the research with an eye to changing federal guidance on MRSA screening in treatment for ICUs, but that probably won't happen right away, CDC officials say.
Gina Pugliese, RN, Vice President of the Premier healthcare alliance's Safety Institute, gave similar advice to hospitals wondering how this research should affect them.
- CVS Ramps Up Retail Clinics with Provider Affiliations
- 4 Tectonic Shifts Shaking Up Healthcare
- Drug Pricing 'Tantamount to Greed,' Lawmaker Says
- Contradictory Obamacare Rulings Issued by Appellate Courts
- Study Puts Spotlight on Preventing Fall-Related Injuries
- Wanted: Nurse PhDs
- As HIPAA Breaches Accelerate, Tools Lag
- Roundtable: Life After a Healthcare Organization Acquisition
- The Infection-Busting Treatment Payers Don’t Want to Talk About
- Medical Errors Third Leading Cause of Death, Senators Told